For example: The STEP 1 trial, published in The New England Journal of Medicine in 2021, found that semaglutide led to significant weight loss and improvements in metabolic markers, with secondary data suggesting modest reductions in lean mass
Getting off GLP-1 medications like semaglutide and tirzepatide is one of the most searched, most misunderstood topics in the weight loss community right now
These symptoms are most noticeable during the first 12 weeks of treatment, often referred to as the dose-escalation phase
For employers, its important to talk with your benefits advisor about whether incorporating biosimilars into your health plan would be right for your organization
Medical Weight Loss Program That You Can Trust At SOBOBA Medical Weight Loss clinics, we have been helping patients successfully lose weight safely in Orange County since 1968
Budget vendors without returns policies have no financial incentive to maintain quality standards
